Screener
Bicara Therapeutics BCAX Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: Bicara Therapeutics’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033429
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Operating lease liability – current portion | 1,140 | 1,117 |
| Total current liabilities | 39,340 | 28,949 |
| Operating lease liability – net of current portion | 301 | 593 |
| Total liabilities | 39,641 | 29,542 |
| Commitments and Contingencies (Note 7) | ||
| Stockholders' equity: | ||
| Preferred stock $0.0001 par value, 10,000,000 shares authorized; 0 shares issued and outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value, 500,000,000 and 500,000,000 shares authorized; 65,547,037 and 56,600,724 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 8 | 7 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bicara Therapeutics's total liabilities?
- Bicara Therapeutics (BCAX) reported total liabilities of $39.64M in Q1 2026.
- How has Bicara Therapeutics's total liabilities changed year-over-year?
- Bicara Therapeutics's total liabilities increased by 107.3% year-over-year, from $19.12M to $39.64M.
- What is the long-term trend for Bicara Therapeutics's total liabilities?
- Over 2 years (2023 to 2025), Bicara Therapeutics's total liabilities has grown at a 38.2% compound annual growth rate (CAGR), from $15.47M to $29.54M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Bicara Therapeutics's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude